MiNA Therapeutics: Funding, Investors & Team (Oct 2026)
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. Its technology helps transform the therapy landscape of cancer and other severe diseases that enable doctors and physicians to cure diseases and develop medicines that restore normal function to patients' cells. The company was founded in 2008 and is headquartered in London, England.
MiNA Therapeutics has raised $38.0M across 2 funding rounds on record, the most recent a Corporate Round of $15.0M announced in Jul 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MiNA Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2021.
MiNA Therapeutics Funding Rounds
MiNA Therapeutics raised $23.0M in an undisclosed round announced in Sep 2020.
10 months later, a Corporate Round of $15.0M was announced in Jul 2021.
MiNA Therapeutics Founders and Leadership Team
Contact details for the MiNA Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →MiNA Therapeutics Funding Compared to Other Biotechnology Startups
MiNA Therapeutics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MiNA Therapeutics in Biotechnology and London
Companies Similar to MiNA Therapeutics
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
MiNA Therapeutics Funding FAQs
What does MiNA Therapeutics do?
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. Its technology helps transform the therapy landscape of cancer and other severe diseases that enable doctors and physicians to cure diseases and develop medicines that restore normal function to patients' cells. The company was founded in 2008 and is headquartered in London, England.
How much funding has MiNA Therapeutics raised?
MiNA Therapeutics has raised $38.0M across 2 rounds on record. The most recent is a Corporate Round of $15.0M announced in Jul 2021.
When did MiNA Therapeutics last raise funding?
MiNA Therapeutics' most recent funding round on record is a Corporate Round of $15.0M, announced in Jul 2021.
Who is the CEO of MiNA Therapeutics?
Robert Habib is listed as CEO at MiNA Therapeutics.
Where is MiNA Therapeutics headquartered?
MiNA Therapeutics is based in London, England, United Kingdom.
How many employees does MiNA Therapeutics have?
MiNA Therapeutics is in the 11-50 employee band.
How does MiNA Therapeutics' funding compare to other Biotechnology startups?
MiNA Therapeutics' latest round of $15.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MiNA Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MiNA Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.